A journey inside the elderly-onset primary Sjögren’s syndrome, looking for useful tips for the geriatrician
https://doi.org/10.4081/gc.2022.10668
Accepted: 6 September 2022
HTML: 72
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Primary Sjögren’s syndrome (pSS) is a systemic autoimmune rheumatic disease where xerophthalmia, xerostomia and presence of anti-SSA and anti-SSB antibodies are typical features. Its prevalence is higher in over-65 aged population than in other age groups. In the elderly, pSS diagnosis comes up against a whole series of critical points that may favor its misdiagnosis. The aim of our article is to discuss the most relevant of them: the frequent occurrence of a seronegative subset, the presence of systemic features not related to sicca syndrome, the sicca syndrome as iatrogenic manifestation and the possibility of a biopsy false negative of labial salivary glands.
Skarlis C, Raftopoulou S, Mavragani CP. Sjogren’s syndrome: recent updates. J Clin Med 2022;11:399. DOI: https://doi.org/10.3390/jcm11020399
Saraux A, Devauchelle-Pensec V. Primary Sjögren’s syndrome: new beginning for evidence-based trials. Lancet 2022;399:121-2. DOI: https://doi.org/10.1016/S0140-6736(21)02644-1
Zandonella Callegher S, Giovannini I, Zenz S, et al. Sjögren syndrome: looking forward to the future. Ther Adv Musculoskelet Dis 2022;14:1759720X221100295. [Epub ahead of print]. DOI: https://doi.org/10.1177/1759720X221100295
Manfrè V, Cafaro G, Riccucci I, et al. One year in review 2020: comorbidities, diagnosis and treatment of primary Sjögren’s syndrome. Clin Exp Rheumatol 2020;38:10-22
Mariette X, Criswell LA. Primary Sjögren’s syndrome. N Engl J Med 2018;378:931-9. DOI: https://doi.org/10.1056/NEJMcp1702514
Yazisiz V, Aslan B, Erbasan F, et al. Clinical and serological characteristics of seronegative primary Sjögren’s syndrome: a comparative study. Clin Rheumatol 2021;40:221-9. DOI: https://doi.org/10.1007/s10067-020-05154-9
Brito-Zerón P, Retamozo S, Ramos-Casals M. Phenotyping Sjögren’s syndrome: towards a personalised management of the disease. Clin Exp Rheumatol 2018;36:198-209.
He J, Jiang J, Baumgart K. Candidate autoantibodies for primary Sjögren’s syndrome: where are they now? Clin Exp Rheumatol 2022 [Epub ahead of print]. DOI: https://doi.org/10.55563/clinexprheumatol/vmqtz4
Negrini S, Emmi G, Greco M, et al. Sjögren’s syndrome: a systemic autoimmune disease. Clin Exp Med 2022;22:9-25. DOI: https://doi.org/10.1007/s10238-021-00728-6
Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 2015;74:1983-9. DOI: https://doi.org/10.1136/annrheumdis-2014-205375
Patel R, Shahane A. The epidemiology of Sjögren’s syndrome. Clin Epidemiol 2014;6:247-55. DOI: https://doi.org/10.2147/CLEP.S47399
Drosos AA, Andonopoulos AP, Costopoulos JS, et al. Prevalence of primary Sjögren’s syndrome in an elderly population. Br J Rheumatol 1988;27:123-7. DOI: https://doi.org/10.1093/rheumatology/27.2.123
Manzo C, Maslinska M. Primary Sjögren’s Syndrome in the elderly: does age of onset make a difference? EMJ Rheumatol 2018;5:75-82.
Manzo C. Questions as regards the recognition of elderly-onset primary Sjögren’s syndrome: Where we are and where we would rather be. Rev Colomb Reumatol 2020;27:75-81. DOI: https://doi.org/10.1016/j.rcreu.2020.05.006
Ripsman DA, Bookman AAM. Correlation between subjective and objective severity of oral and ocular dryness in primary Sjögren syndrome. J Rheumatol 2021;48:1290-4. DOI: https://doi.org/10.3899/jrheum.200907
Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc 2003;134:61-9. DOI: https://doi.org/10.14219/jada.archive.2003.0018
Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data‐driven methodology involving three international patient cohorts. Arthritis Rheumatol 2017;69:35-45. DOI: https://doi.org/10.1002/art.39859
Baldini C, Talarico R, Tzioufas AG, Bombardieri S. Classification criteria for Sjogren’s syndrome: a critical review. J Autoimmun 2012;39:9-14. DOI: https://doi.org/10.1016/j.jaut.2011.12.006
Both T, Dalm VA, van Hagen PM, van Daele PL. Reviewing primary Sjögren’s syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment. Int J Med Sci 2017;14:191-200. DOI: https://doi.org/10.7150/ijms.17718
Zhang Y, Li M, Zhang L, et al. Association between comorbidities and extraglandular manifestations in primary Sjögren’s syndrome: a multicenter cross-sectional study.Clin Rheumatol 2020;39:2677-88. DOI: https://doi.org/10.1007/s10067-020-04992-x
Mathews PM, Robinson SA, Gire A, et al. Extraglandular ocular involvement and morbidity and mortality in primary Sjögren’s syndrome. PLoS One 2020;15:e0239769. DOI: https://doi.org/10.1371/journal.pone.0239769
Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y. Sjögren’s syndrome, the old and the new. Best Pract Res Clin Rheumatol 2012;26:105-17. DOI: https://doi.org/10.1016/j.berh.2012.01.012
Manzo C, Martinez-Suarez E, Kechida M, et al. Cognitive function in primary Sjögren’s syndrome: a systematic review. Brain Sci 2019;9:85. DOI: https://doi.org/10.3390/brainsci9040085
Maslinska M, Kontny E, Kwiatkowska B. The relationship between the presence of autoantibodies, indicator of local and systemic inflammation, the serum concentration of B-cell activating factor (BAFF) and the intensity of salivary gland infiltration in patients with Sjögren’s syndrome- a preliminary study. Reumatologia 2015;53:321-7. DOI: https://doi.org/10.5114/reum.2015.57638
Du W, Han M, Zhu X, et al. The multiple roles of B cells in the pathogenesis of Sjögren’s syndrome. Front Immunol 2021;12:684999. DOI: https://doi.org/10.3389/fimmu.2021.684999
Ramos-Casals M, García-Carrasco M, Cervera R. Sjögren’s syndrome and hepatitis C virus. Font J Clin Rheumatol 1999;18:93-100. DOI: https://doi.org/10.1007/s100670050064
Marcos M, Alvarez F, Brito-Zerón P, et al. Chronic hepatitis B virus infection in Sjögren’s syndrome. Prevalence and clinical significance in 603 patients. Autoimmun Rev 2009;8:616-20. DOI: https://doi.org/10.1016/j.autrev.2009.02.007
Bautista-Vargas M, Vivas AJ, Tobón GJ. Minor salivary gland biopsy: Its role in the classification and prognosis of Sjögren’s syndrome. Autoimmun Rev 2020;19:102690. DOI: https://doi.org/10.1016/j.autrev.2020.102690
Guellec D, Cornec D, Jousse-Joulin S, et al. Diagnostic value of labial minor salivary gland biopsy for Sjögren’s syndrome: a systematic review. Autoimmun Rev 2013;12:416-20. DOI: https://doi.org/10.1016/j.autrev.2012.08.001
Shiboski SC, Shiboski CH, Criswell LA, et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the SICCA cohort. Arthritis Care Res (Hoboken) 2012;64:475-87. DOI: https://doi.org/10.1002/acr.21591
Moerman RV, Bootsma H, Kroese FG, Vissink A. Sjögren’s syndrome in older patients: aetiology, diagnosis and management. Drugs Aging 2013;30:137-53. DOI: https://doi.org/10.1007/s40266-013-0050-7
Schäfer VS, Schmidt WA. Ultrasound diagnostics in Sjögren’s syndrome. Z Rheumatol 2017;76:589-94 [Article in German]. DOI: https://doi.org/10.1007/s00393-017-0305-5
Geng Y, Li B, Deng X, et al. Salivary gland ultrasound integrated with 2016 ACR/EULAR classification criteria improves the diagnosis of primary Sjögren’s syndrome. Clin Exp Rheumatol 2020;38:322-8. DOI: https://doi.org/10.55563/clinexprheumatol/13u0rt
Zabotti A, Zandonella Callegher S, Lorenzon M, et al. Ultrasound-guided core needle biopsy compared with open biopsy: a new diagnostic approach to salivary gland enlargement in Sjögren’s syndrome? Rheumatology (Oxford) 2021;60:1282-90. DOI: https://doi.org/10.1093/rheumatology/keaa441
Nieto-González JC, Ovalles-Bonilla JG, Estrada E, et al. Salivary gland ultrasound is linked to the autoimmunity profile in patients with primary Sjögren’s syndrome. J Int Med Res 2020;48:300060518767031. DOI: https://doi.org/10.1177/0300060518767031
Silva JL, Faria DS, Neves JS, et al. Salivary gland ultrasound findings are associated with clinical and serologic features in primary Sjögren’s syndrome patients. Acta Reumatol Port 2020;45:76-7.
Smidt D, Torpet LA, Nauntofte B, et al. Association between labial and whole salivary flow rates, systemic diseases and medications in a sample of older people. Community Dent Oral Epidemiol 2010;38:422-35. DOI: https://doi.org/10.1111/j.1600-0528.2010.00554.x
Maslinska M, Manzo C. Sindrome di Sjögren primaria nell’ anziano: l’età di insorgenza realizza differenze?. G It Reumatol Clin 2018;1:31-44 [Article in Italian].
Wolff A, Joshi RK, Ekström J, et al. A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the World Workshop on Oral Medicine VI. Drugs R D 2017;17:1-28. DOI: https://doi.org/10.1007/s40268-016-0153-9
Baer AN, Walitt B. Update on Sjögren syndrome and other causes of sicca in older adults. Rheum Dis Clin North Am 2018;44:419-36. DOI: https://doi.org/10.1016/j.rdc.2018.03.002
Syrianen S. Age-related changes in structure of labial minor salivary glands. Age Ageing 1984;13:159-65. DOI: https://doi.org/10.1093/ageing/13.3.159
Schein OD, Munoz B, Tielsch IM, et al. Prevalence of dry eye among the elderly. Am J Opthalmol 1997;124:723-8. DOI: https://doi.org/10.1016/S0002-9394(14)71688-5
Lin PY, Tsai SY, Cheng CY, et al. Prevalence of dry eye among Chinese population in Taiwan: the Shilpai Eye study. Opthalmology 2003;110:1096-101. DOI: https://doi.org/10.1016/S0161-6420(03)00262-8
Whitcher JP, Shiboski CH, Shiboski SC, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s Syndrome International Registry. Am J Ophthalmol 2010;149:405-15. DOI: https://doi.org/10.1016/j.ajo.2009.09.013
Buchner A, Sreebny LM. Enlargement of salivary glands. Review of the literature. Oral Surg Oral Med Oral Pathol 1972;34:209-22. DOI: https://doi.org/10.1016/0030-4220(72)90411-2
Tishler M, Yaron I, Shirazi I, Yaron M. Clinical and immunological characteristics of elderly-onset syndrome: a comparison with younger onset disease. J Rheumatol 2001;28:795-7.
Brito-Zeron P, Acar-Denizli N, Ng WF, et al. How immunological profile drives clinical phenotype of primary Syogren’s syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). Clin Exp Rheumatol 2018;36:S102-S112.
Botsios C, Furlan A, Ostuni P, et al. Elderly onset of primary Sjögren’s syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Joint Bone Spine 2011;78:171-4. DOI: https://doi.org/10.1016/j.jbspin.2010.05.008
Chebbi W, Ben Salem W, Klii R, et al. Primitive Sjögren syndrome in the elderly: clinical and immunological characteristics. Pan Afr Med J 2015; 20:8. DOI: https://doi.org/10.11604/pamj.2015.20.8.5042
Garcia-Carrasco M, Ramos-Casals M, Rosas J, et al. Primary Sjögren syndrome: clinical and immunological disease patterns in a cohort of 400 patients. Medicine 2002;81:270-80. DOI: https://doi.org/10.1097/00005792-200207000-00003
Vivino FB, Gala I, Hermann GA. Change in final diagnosis on second evaluation of labial minor salivery gland biopsies. J Rheumatol 2002;29:938-44.
Costa S, Quintin-Roue I, Lesourd A, et al. Reliability of histopathological salivary gland biopsy assessment in Sjögren’s syndrome: a multicenter cohort study. Rheumatology (Oxford) 2015;54:1056-64. DOI: https://doi.org/10.1093/rheumatology/keu453
Vered M, Buchner A, Boldon P, Dayan D. Age-related histomorphometric changes in labial salivary gland with special reference to the acinar component. Exp Gerontol 2000;35:1075-84. DOI: https://doi.org/10.1016/S0531-5565(00)00129-7
Leehan KM, Pezant NP, Rasmussen A, et al. Fatty infiltration of the minor salivary glands is a selective feature of aging but not Sjögren’s syndrome. Autoimmunity 2017;50:451-7. DOI: https://doi.org/10.1080/08916934.2017.1385776
Manzo C. Labial salivary gland biopsy and secondary Sjögren’s syndrome: where we are and where we want to be. Reumatologia 2019;57:354-5. DOI: https://doi.org/10.5114/reum.2019.91274
Manthorpe R, Benoni C, Jacobsson L, et al. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren’s syndrome? Ann Rheum Dis 2000;59:54-60. DOI: https://doi.org/10.1136/ard.59.1.54
Tarpley TM jr, Anderson LG, White CL. Minor salivary gland involvement in Sjögren’s syndrome. Oral Surg Oral Med Oral Pathol 1974;37:64-74. DOI: https://doi.org/10.1016/0030-4220(74)90160-1
Fisher BA, Jonsson R, Daniels T, et al. Standardisation of labial salivary gland histopathology in clinical trial in primary Sjögren’s syndrome. Ann Rheum Dis 2017;76:1161-8. DOI: https://doi.org/10.1136/annrheumdis-2016-210448
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
